[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North America Molecular Diagnostic Analyzers and Reagents Market 2021: USA, Canada, Mexico--Supplier Shares by Test, Competitive Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

June 2017 | 1170 pages | ID: N1365FD6F8BEN
Venture Planning Group

US$ 9,540.00 US$ 10,600.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 3- country report from VPGMarketResearch.com is available by country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights
  • Supplier sales and market shares in major countries
  • Five- year test volume and sales forecasts
  • Strategic profiles of market players and start- up firms developing innovative technologies and products
  • Emerging technologies
  • Review of molecular diagnostic analyzers
  • Specific product and business opportunities for instrument and consumable suppliers
Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost- effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Country Analyses

Canada, Mexico, USA

Market Segmentation Analysis
  • Sales and market shares of key suppliers of molecular diagnostic reagent kits and components in major markets.
Five- year test volume and sales forecasts for major applications, including:- Infectious Diseases - Forensic Testing- Cancer - Paternity Testing/HLA Typing- Genetic Diseases - Others- Five- year test volume and sales projections for over 30 NAT assays.- A comprehensive analysis of the sequencing market, by country and laboratory segment, including:- Industrial - Academic- Government - Commercial
  • Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and suppliers in major countries.

    Product/Technology Review
    • Comparison of leading molecular diagnostic analyzers marketed by Abbott, Beckman Coulter, BD, Bio- Rad, Hologic, Roche, Tecan and other suppliers.
    • Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
    • PCR - bDNA
    • SDA - NASBA
    • TMA - SSSR, and others
    • LCR
    • Universities and research centers developing new molecular diagnostic technologies and products.
    Competitive Assessments
    • Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
    • Companies developing and marketing molecular diagnostics products, by test and application.
    Opportunities and Strategic Recommendations
    • Specific new product development opportunities with potentially significant market appeal during the next five years.
    • Design criteria for new products.
    • Alternative market penetration strategies.
    • Potential market entry barriers and risks.
    • Business planning issues and concerns.
    Contains 1,170 pages and 75 tables
  • I. INTRODUCTION

    II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. Instrumentation
    B. Reagent Kits and Test Systems/panels
    C. Computers, Software and Automation
    D. Auxiliary Products

    III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets

    V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    VI. MARKET AND TECHNOLOGY REVIEW

    A. DNA Sequencing
      1. INTRODUCTION
      2. SEQUENCING METHODS
      3. AUTORADIOGRAPHY
      4. THE HUMAN GENOME PROJECT
      5. SEQUENCING AUTOMATION
      6. IMAGE SCANNERS
      7. FLUORESCENT DETECTION
      8. GENE PROFILING
      9. GENE EXPRESSION
      10. POLYMORPHISM SCREENING
      11. PROTEIN INTERACTION NETWORKS
    B. DNA and RNA Probe Technologies
      1. BASIC PRINCIPLES
      2. PROBE PREPARATION
      3. THE DNA PROBE TEST
      4. TEST FORMATS
      5. LABELING TECHNIQUES
      6. AMPLIFICATION METHODS
    C. Detection Technologies
      1. RADIOACTIVE METHODS
        a. Overview
        b. Major Isotopes
      2. NON-ISOTOPIC METHODS
        a. Enzymatic Labels
        b. Chemical Labeling
        c. Fluorescence
        d. Chemiluminescence
        e. Electrical Conductivity
    D. Molecular Diagnostic Instrumentation Review
      1. ABBOTT LCX
      2. BECKMAN COULTER/BIOMEK FK
      3. BD VIPER SYSTEM WITH XTR TECHNOLOGY
      4. BD INNOVA
      5. BECTON DICKINSON SDA
      6. BIOMERIEUX NUCLISENS EASYMAG
      7. BIOMERIEUX NUCLISENS EASYQ AND MINIMAG
      8. BIO-RAD GENESCOPE
      9. CEPHEID GENEXPERT
      10. CURETIS UNYVERO
      11. GENMARK DX ESENSOR XT-8
      12. HOLOGIC/GEN-PROBE PANTHER
      13. HOLOGIC/GEN-PROBE TIGRIS/DTS
      14. HTG MOLECULAR EDGE
      15. LIFE TECHNOLOGIES QUANTSTUDIO DX
      16. QIAGEN QIASYMPHONY RGQ
      17. ROCHE COBAS AMPLICOR
      18. ROCHE COBAS TAQMAN
      19. ROCHE COBAS TAQMAN
      20. ROCHE COBAS TAQMAN AMPLIPREP
      21. ROCHE LIGHCYCLER
      22. ROCHE COBAS 4800
      23. ROCHE COBAS S
      24. SIEMENS VERSANT
      25. TECAN LS SERIES
    E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
      Liquid Transportation and Mixing
      Separation
      Reaction
      Detection
    F. Pharmacogenomics
    G. Major Applications
      1. MICROBIOLOGY/INFECTIOUS DISEASES
        a. Overview
        b. Major Infectious Diseases
          AIDS/HIV
          Adenovirus
          Aeromonads
          Anthrax/Bacillus Anthracis
          Arboviruses
          Babesiosis
          Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
          Blastocystis Hominis
          Brucella
          Campylobacter
          Candida
          Chagas Disease
          Chancroid
          Chlamydia
          Clostridium Difficile
          Coronaviruses
          Coxsackieviruses
          Creutzfeldt-Jakob’s Disease
          Cryptosporidium Parvum
          Cyclospora Cayetanensis
          Cytomegalovirus
          Ebola Virus
          E. Coli
          EchoVirus
          Encephalitis
          Enteroviruses
          Epstein-Barr Virus
          Giardia Lamblia
          Gonorrhea
          Granuloma Inguinale
          Hantavirus
          Helicobacter Pylori
          Hepatitis
          Herpes Simplex Virus
          Human Herpes Virus-6 (HHV-6)
          Influenza Viruses
          Legionella
          Lyme Disease
          Lymphogranuloma Venereum (LGV)
          Malaria
          Measles (Rubeola)
          Meningitis
          Microsporidium
          Mononucleosis
          Mumps
          Mycoplasma
          Papillomaviruses
          Parvovirus B19
          Pneumonia
          Polyomaviruses
          Pseudomonas Aeruginosa
          Rabies
          Respiratory Syncytial Virus (RSV)
          Rhinoviruses
          Rotavirus
          Rubella
          Salmonellosis
          Septicemia
          Shigellosis
          Staphylococcus Aureus
          Streptococci
          Syphilis
          Toxoplasmosis
          Trichomonas Vaginalis
          Tuberculosis
          Vibrio
          West Nile Virus
          Yersina
      2. CANCER TESTING
        a. Overview
        b. Major Cancer Types
          Prostate
          Lung
          Colon and Rectum
          Breast
          Skin
          Uterine
          Leukemia
          Oral
        c. Oncogenes
          Abl/abl-bcr
          AIB1
          BCL-2
          BRCA1
          CD44
          C-fos
          C-myb
          C-myc
          CYP17
          Erb-B
          HPC1
          N-myc
          P40
          P51
          P53
          PIK3CA
          PTI-1
          Ras
          Reg
          Sis
          Src
      3. GENETIC DISEASES
        a. Overview
        b. Nucleic Acid Amplification
        c. Chromosome Imaging
        d. Genomics Technologies
        e. Proteomics Technologies
        f. Current Pharmacogenomic Tests
        g. Future Pharmacogenomic Testing
        h. Major Diseases
          Achondroplasia
          Autosomal Dominant Polycystic Kidney Disease
          Cancer
          Cosmetogenomics
          Cystic Fibrosis
          Down's Syndrome
          Duchenne and Becker Muscular Dystrophy
          Factor V (Leiden)
          Factor IX Deficiency
          Fragile X Syndrome
          Heart Disease
          Hemochomatosis
          Hemophilia
          Huntington's Disease
          Maternal-Fetal Incompatibility
          Multiple Endocrine Neoplasia
          Phenylketonuria (PKU)
          Polycystic Kidney Disease (PKD)
          Prenatal Screening
          Retinitis Pigmentosa
          Retinoblastoma
          Sickle Cell Anemia
          Spinal Muscular Atrophy
          Vitamin B12 Metabolism
        i. Social Issues and Concerns
      4. FORENSIC TESTING
        a. Overview
        b. Multilocus and Single Locus Probes
        c. DNA Profile Data Banks
        d. Judicial Implementation
        e. Major Crime Categories
        f. Factors Contributing to the DNA Probe Market Expansion
          Technology Availability
          Use of Hair as Evidence
        g. Wildlife Forensics
      5. PATERNITY TESTING/HLA TYPING
      6. OTHER APPLICATIONS
        a. Disease Susceptibility Testing
        b. Cardiovascular Diseases
        c. Diabetes
        d. Alzheimer's Disease
        e. Periodontal Disease
        f. Plasma Purification
        g. Organ Transplantation
        h. Water Contamination
        i. Other
    H. Competing/complementing
      1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
      2. RNA PROBES
      3. TWO-DIMENSIONAL ELECTROPHORESIS
      4. FLOW CYTOMETRY

    VII. COUNTRY ANALYSES: VOLUME AND SALES FORECASTS--INFECTIOUS DISEASES, GENETIC DISEASES, CANCER, FORENSIC AND PATERNITY TESTING

    Canada
    Mexico
    USA

    VIII. COMPETITIVE ASSESSMENTS

    Abbott
    Affymetrix/Thermo Fisher
    Agilent Technologies
    Applied Gene Technologies
    Arca Biopharma
    Beckman Coulter/Danaher
    Becton Dickinson
    Biokit
    bioMerieux
    Bio-Rad
    Biotest
    CellMark Forensics/LabCorp
    Cepheid
    Decode Genetics
    Diadexus
    Eiken
    Elitech Group
    Enzo
    Exact Sciences
    Fujirebio
    Grifols
    Hologic/Gen-Probe
    Illumina
    Kreatech/Leica
    Li-Cor Biosciences
    Monogram Biosciences/LabCorp
    Myriad Genetics
    Ortho-Clinical Diagnostics
    Perkin Elmer/Caliper
    Proteome Sciences
    Qiagen
    Roche
    Scienion
    Sequenom
    Shimadzu
    Siemens
    Sierra Molecular
    Takara Bio
    Tecan Group

    IX. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING INNOVATIVE MOLECULAR DIAGNOSTIC TECHNOLOGIES AND PRODUCTS

    LIST OF TABLES

    Canada Molecular Diagnostics Test Volume and Sales Forecasts by Application
    Canada Molecular Diagnostics Test Volume Forecasts by Application
    Canada Major Infectious Disease Test Volume Forecasts by Assay
    Canada Molecular Diagnostics Market Forecasts by Application
    Canada Major Infectious Disease Diagnostics Market Forecasts by Assay
    Mexico Molecular Diagnostics Test Volume and Sales Forecasts by Application
    Mexico Molecular Diagnostics Test Volume Forecasts by Application
    Mexico Major Infectious Disease Test Volume Forecasts by Assay
    Mexico Molecular Diagnostics Market Forecasts by Application
    Mexico Major Infectious Disease Diagnostics Market Forecasts by Assay
    U.S.A. Molecular Diagnostics Test Volume and Sales by Major Application
    U.S.A. Laboratories Performing DNA Sequencing by Market Segment
    U.S.A. Echovirus Testing Market Estimated Sales by Major Supplier
    U.S.A. Enterovirus Testing Market Estimated Sales by Major Supplier
    U.S.A. EBV Testing Market Estimated Sales by Major Supplier
    U.S.A. Gonorrhea Testing Market Estimated Sales by Major Supplier
    U.S.A. Hepatitis Testing Market Estimated Sales by Major Supplier
    U.S.A. Hepatitis C Testing Market Estimated Sales by Major Supplier
    U.S.A. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    U.S.A. Herpes Testing Market Estimated Sales by Major Supplier
    U.S.A. Influenza Testing Market Estimated Sales by Major Supplier
    U.S.A. Meningitis Testing Market Estimated Sales by Major Supplier
    U.S.A. Mycoplasma Testing Market Estimated Sales by Major Supplier
    U.S.A. Pneumonia Testing Market Estimated Sales by Major Supplier
    U.S.A. Rabies Testing Market Estimated Sales by Major Supplier
    U.S.A. RSV Testing Market Estimated Sales by Major Supplier
    U.S.A. Salmonella Testing Market Estimated Sales by Major Supplier
    U.S.A. Shigella Testing Market Estimated Sales by Major Supplier
    U.S.A. West Nile Virus Nat Market Reagent Sales by Major Supplier
    Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests Oncogenes Potential Application in Cancer Diagnosis
    Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
    Major Companies Developing or Marketing Molecular Diagnostic Tests for Genetic Diseases


    More Publications